Arena’s Anti-Obesity Drug Gets Commercial Partner before Approval Decision

By Staff Editor;

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 2 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1356     ISSN: 1756-7874

Section: Distribution & Marketing



Arena Pharmaceuticals has finally found a US commercial partner for its anti-obesity drug lorcaserin, which is currently awaiting regulatory approval from the FDA, by signing a marketing and supply agreement with Eisai...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details